INTRODUCTION
The multicatalytic proteinase complex (MCP) or proteasome is a high-molecular-mass proteinase (multicatalytic endopeptidase complex, EC 3.4.99.46) that is found in the nucleus and cytoplasm of eukaryotic cells (see [1, 2] for reviews). MCP is a major nonlysosomal proteinase and appears to be involved in ubiquitindependent as well as ubiquitin-independent non-lysosomal pathways of protein degradation [3] [4] [5] . In addition, it is now believed to play a part in antigen processing [6, 7] . The enzyme complex can degrade a variety of protein and peptide substrates [1] . It catalyses cleavage on the carboxy side of basic, hydrophobic or acidic amino acid residues [8] . These activities, which have been referred to, although possibly inappropriately, as 'trypsin-like', 'chymotrypsin-like' and peptidylglutamyl-peptide hydrolase activities respectively, appear to be catalysed at distinct sites [9] [10] [11] .
Like other MCPs, the rat liver proteinase is composed of at least 24 subunits arranged in a hollow cylindrical structure. Highly purified proteinase preparations contain more than twenty different polypeptides, all of molecular mass 22-35 kDa and pl values ranging from 4 to 9 [12] . Comparisons of Nterminal amino acid sequences of several rat MCP polypeptides [13] and of complete amino acid sequences deduced from cDNA sequences [14] , as well as similar observations made for subunits of the proteinase isolated from Drosophila [15] , human [16] , and yeast have shown that several of the subunits are encoded by members ofthe same gene family. Sequence comparisons have so far failed to demonstrate any close similarity between MCP polypeptides and other known proteinases, although it is assumed that several of the subunits have proteolytic functions. Despite many studies of the proteinase isolated from a variety of different sources, there is little information regarding the function of individual subunits, and it is not clear which of the many polypeptides are responsible for the distinct proteolytic activities.
As part of a broader study of possible relationships between the different polypeptides of rat liver MCP [12, 13] , the purpose and completely inhibited by peptidyl arginine aldehydes (such as leupeptin and antipain), and is also the most sensitive to inhibition by thiol-reactive reagents. In the present study N-[ethyl-_-14C]ethylmaleimide has been used to specifically label thiol groups protected by leupeptin binding. The results suggest that one or two polypeptide components within the complex can be protected against modification by N-ethylmaleimide. These components may be responsible for the 'trypsin-like' activity of the complex or may be adjacent to the catalytic component(s) and play an important role in substrate binding.
of the present experiments was to investigate which subunit(s) of the rat liver MCP complex are associated with the 'trypsin-like' activity. Here we have used this term to refer to the activity which is responsible for catalysing the hydrolysis of the synthetic peptide substrate N-Boc(t-butoxycarbonyl)-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin (LSTR-AMC), although its specificity is not the same as that of trypsin (H. Djaballah and A. J. Rivett, unpublished work). Leupeptin, a peptide arginine aldehyde, which is a reversible inhibitor of serine and cysteine proteinases, selectivity inhibits the 'trypsin-like' activity [8, 10] . This activity is also the most sensitive to inhibition by thiol-reactive reagents, and in the present study N-[ethyl-l-4C]ethylmaleimide (["C]-NEM) has been used successfully to label subunits which are protected by leupeptin binding. A preliminary account of these results. has already been presented [17] .
MATERIALS AND METHODS

Materials
[14C]NEM (sp. radioactivity 40Ci/mol) was purchased from New England Nuclear. LSTR-AMC was purchased from The Peptide Institute, and Ala-Ala-Phe-7-amido-4-methylcoumarin (AAF-AMC), N-Cbz(benzyloxycarbonyl)-Leu-Leu-Glu-fnaphthylamide (LLE-NA), leupeptin and NEM were from Sigma. MCP was purified from fresh rat livers as described previously [121.
Amino acid analysis and the determinafton of protein concentration Protein concentrations were routinely determined by the method of Bradford [18] , with BSA as standard, because MCP was found to give a colour reaction in the dye-binding assay [18] that is almost identical with that of BSA ([MCP] = 0.96 x concentration determined using BSA). This value was determined by using results based on amino acid analysis. MCP (dialysed against Abbreviations used: AAF-AMC, Ala-Ala-Phe-7-amido-4-methylcoumarin; Boc, t-butoxycarbonyl; Cbz, benzyloxycarbonyl; LLE-NA, Cbz-Leu-LeuGlu-fl-naphthylamide; LSTR-AMC, N-Boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin; NEM, N-ethylmaleimide; MCP (Figure 1 ). For some proteinases, apparent slow binding occurs because of the rate of interconversion of inactive forms of leupeptin into the active inhibitor, which only constitutes 2 % of the total [22] . However, in the case of MCP, the on-rate is substantially lower than the rate of conversion from inactive into active inhibitor. Leupeptin forms a hemiacetal derivative of the catalytic serine residue of serine proteinases [23] . Inhibition of MCP by leupeptin can be reversed slowly, either by dialysis to remove the leupeptin or by reaction with NaBH4, to produce the peptidyl alcohol, which is non-inhibitory at concentrations up to at least 100 ,uM. Complete re-activation of the leupeptin-inhibited 'trypsin-like' activity can be achieved by dilution into an assay mix containing 20 mM NaBH4, but no reactivation was observed when the enzyme was diluted for assay in the absence of NaBH4 (Figure 1 ). The result of addition of NaBH4 to leupeptin-treated MCP depended on the precise concentrations of leupeptin, and without dilution sometimes resulted in only a 30-50 % recovery of activity in 1 h, even with repeated additions of NaBH4 (Figure 1 ). These observations reflect the low Ki value, determined to be less than 1 /M (results not shown) and the slow off-rate of leupeptin, which is also evidenced by the long dialysis period required to recover full activity of leupeptin-treated MCP in the absence of NaBH4.
Conditions for complete recovery of LSTR-AMC-hydrolysing activity were found for the labelling experiments (see below). Of the thiol-reactive reagents tested previously [10] , NEM (1 mM) was found to inhibit the 'trypsin-like' activity of rat liver MCP, while having rather little effect on other activities of the complex. Almost complete inhibition of proteolytic activity Table 1 Effect of leupeptin, antipain and NEM on rat liver MCP activities Assays of proteinase activity were carried out for 30 min at 37 OC in 50 mM Hepes buffer, pH 8.0, after preincubation of proteinase with inhibitor for 30 min at 20 OC in the same buffer followed by a 10-fold dilution into the assay mix. (a) assayed with LSTR-AMC as substrate can be achieved within + -1 h with 5 mM NEM (Table 1) . At this higher concentration, NEM does inhibit the peptidylglutamyl-peptide hydrolase activity, but this observation does not affect the labelling experiments, because leupeptin is specific for the 'trypsin-like' activity except when used at concentrations above 100 ,uM. Inhibition of ui 'trypsin-like' activity by NEM, unlike that by leupeptin, is irreversible and unaffected by NaBH4 (Figure 1 ). If MCP is preincubated with leupeptin prior to the addition of NEM, the LSTR-AMC-hydrolysing activity can be recovered following removal of excess NEM and leupeptin (Figure 1) . However, the resulting modified active enzyme appears to be much less sensitive to inhibition by subsequent treatment with NEM than the untreated enzyme, and often a maximum of only 30-70 % (b)
inhibition could be obtained. If, as we now believe to be the case, the thiol groups are not essential for catalytic activity, these observations could be explained by a minor change in conformation in the modified enzyme. Alternatively they might be due to incomplete removal of bound leupeptin if residual trypsinlike activity were activated to give an apparent 1000% recovery. specific for cysteine residues- [24] , but labelling of the enzyme could be blocked by prior treatment with unlabelled reagent (10 mM) . A total number of 113 cysteine residues per molecule was determined from the amino acid analysis. The cysteine content is somewhat higher than that reported for rat liver MCP *0 by Tanaka et al. [25] , which may be explained by our improved analysis of this amino acid (as cysteic acid) following performic acid oxidation. There appear to be some differences in amino acid composition for MCPs isolated from different sources [26, 27] (Figure 2c ). On the basis of the reactivity of MCP with some inhibitors of serine proteinases, we now believe the enzyme to be a novel type of serine protease [28] , and the 'trypsin-like' activity can be completely inhibited by the serine-proteinase inhibitor 4-(2-aminoethyl)benzenesulphonyl fluoride. The results presented here suggest that the 'trypsin-like' activity of MCP may be associated with only one or two polypeptide components of the complex. It seems unlikely that the labelled cysteines are catalytic residues. Therefore it is possible that polypeptides identified in the present study are adjacent to catalytic subunits and involved only in substrate binding rather than being catalytic subunits themselves. However, the conclusion that an activity is catalysed by only one or two subunits within the MCP complex is consistent with results of recent studies showing loss of the 'chymotrypsinlike' activity in a yeast mutant lacking the MCP PREl gene [5] .
